QNTM
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
QNTM
11 hedge funds and large institutions have $476K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
21% less funds holding
Funds holding: 14 → 11 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
11
Holding in Top 10
–
Calls
$15K
Puts
$1K
Top Buyers
| 1 | +$111K | |
| 2 | +$11.3K | |
| 3 | +$9.51K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.49K |
| 5 |
Renaissance Technologies
New York
|
+$4.34K |
Top Sellers
| 1 | -$12.5K | |
| 2 | -$9.59K | |
| 3 | -$2.28K | |
| 4 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$1.02K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$45 |